Table 1.
Radiotracer | Abbreviation | Application | Radiosynthesis | Dosimetry | Historical Imaging |
---|---|---|---|---|---|
[11C]Radiotracers | |||||
[11C]Acetate | [11C]ACE | Metabolism | Runkle et al. 2011 | Seltzer et al. 2004 | Duvernoy et al. 2016 |
[11C]Aminocyclohexane carboxylic acid | [11C]ACHC | Amino acid transport | Koeppe et al. 1990a | Washburn et al. 1982a | Koeppe et al. 1990a |
1-[11C]Methyl-4- piperidinyl n-butyrate | [11C]BMP | Butyrlcholinesterase | Snyder et al. 2001 | Virta et al. 2008 | Kuhl et al. 2006 |
[11C]Butanol | [11C]BUT | Blood flow | See Supporting Information | See Supporting Information | b; Quarles et al. 1993 |
[11C]Carfentanil | [11C]CFN | Mu opioid receptors | Blecha et al. 2017 | Newberg et al. 2009 | Zubieta et al. 2000 |
[11C]Choline | [11C]CHO | Choline biochemistry | Shao et al. 2014 | Tolvanen et al. 2010 | Piert et al. 2009 |
[11C]DASB | [11C]DASB | Serotonin transporter | Shao et al. 2014 | Lu et al. 2004 | Albin et al. 2008 |
[11C]Dihydrotetrabenazine | [11C]DTBZ | Vesicular monoamine transporter 2 (VMAT2) | Shao et al. 2014 | Murthy et al. 2008 | Koeppe et al. 1995 |
[11C]Epinephrine | [11C]EPI | Norepinephrine Transporter (NET) | Chakraborty et al. 1993 | Wrobel et al. 1997 | Münch et al. 2000 |
[11C]Flumazenil | [11C]FMZ | GABAA Receptors | Shao et al. 2011a | Laymon et al. 2012 | Koeppe et al. 1991 |
[11C]meta-Hydroxyephedrine | [11C]HED | NET, Sympathetic nervous system | Shao et al. 2014 | Wrobel et al. 1997 and Supporting Information | Duvernoy et al. 2016 |
[11C]LY2795050 | [11C]LY2795050 | Kappa opioid receptors | Yang et al. 2018 | See Supporting Information | b; Naganawa et al. 2015 |
[11C]Methionine | [11C]MET | Amino acid | Shao et al. 2014 | Deloar et al. 1998 | Miller et al. 2019 |
[11C]Methoxytetrabenazine | [11C]MTBZ | VMAT2 | DaSilva et al. 1993a | Wrobel et al. 1997 | Vander Borght et al. 1995 |
[11C]Methylphenidate | [11C]MPH | Dopamine transporter | Moran et al. 2010 | See Supporting Information | Albin et al. 2009 |
[11C]N-Methylpiperidinyl benzilate | [11C]NMBP | mAChR | Mulholland et al. 1995 | Mulholland et al. 1995 | Zubieta et al. 2001 |
[11C]OMAR/[11C]JHU 75528 | [11C]OMAR | Cannabinoid 2 receptors | Shao et al. 2015 | Wong et al. 2010 | Wong et al. 2010 |
[11C]Palmitate | [11C]PALM | Fatty acid metabolism | Runkle et al. 2011 | Christensen et al. 2017 | b; de Jong et al. 2009 |
[11C]PBR28 | [11C]PBR28 | Translocator protein 18 kDa (TSPO) | Shao et al. 2014 | Brown et al. 2007 | b Kreisl et al. 2016 |
[11C]Pittsburgh Compound B | [11C]PiB | Amyloid plaques | Shao et al. 2014 | O’Keefe et al. 2009 | Burke et al. 2011 |
[11C]((E)-N-(3-iodoprop-2-enyl)-2β-(4′-tolyl) nortropane) | [11C]PE2I | Dopamine transporter | Dollé et al. 2000; Halldin et al. 2003 | Ribeiro et al. 2007 | b; Halldin et al. 2003 |
[11C]Phenylephrine | [11C]PHEN | NET | Del Rosario et al. 1996 | Wrobel et al. 1997 | Raffel et al. 1996 |
(R)-[N-Methyl-11 C]PK11195 | [11C]PK11195 | TSPO | Alves et al., 2013 | Hirvonen et al. 2010 | Junck et al. 1989 |
[11C]PMP | [11C]PMP | Acetylcholinesterase | Shao et al. 2014 | See Supporting Information | Kuhl et al. 1999 |
[11C]Raclopride | [11C]RAC | Dopamine D2 receptors | Shao et al. 2014 | Ribeiro et al. 2005 | Scott et al. 2006 |
[11C]Ro-54,864 | [11C]Ro-54,864 | TSPO | Watkins et al. 1988 | see Supporting Informationa | Junck et al. 1989 |
[11C]Sarcosine | [11C]SARC | Sarcosine biochemistry | Piert et al. 2017 | Piert et al. 2017 | Piert et al. 2017 |
[11C]Scopolamine | [11C]SCOP | mAChR | Mulholland et al. 1988 | Frey et al. 1992 | Frey et al. 1992 |
[11C]Tetrabenazine | [11C]TBZ | VMAT2 | DaSilva et al. 1993b | DaSilva et al. 1994 | Kilbourn et al. 1993 |
[11C]Tropanylbenzilate | [11C]TRB | mAChR | Mulholland et al. 1992 | Mulholland et al. 1992 | Koeppe et al. 1994 |
[11C]WAY-100365 | [11C]WAY | 5-HT1A Receptor | Krasikova et al. 2009 | Parsey et al. 2005 | Mickey et al. 2008 |
[18F]Radiotracers | |||||
[18F]Flortaucipir | [18F]AV1451; [18F]T807; Tauvid | Tau | c; Mossine et al. 2017 | Choi et al. 2016 | Drake et al. 2019; Kramer et al. 2020 |
3-(1,4-Diazabicyclo[3.2.2] nonan-4-yl)-6-[18F]fluoro-dibenzo[b,d]thiophene 5,5-dioxide | [18F]JHU82132, [18F]ASEM | α7 nicotinic acetylcholine receptor (nAChR) | Gao et al. 2013 and Supporting Information | Wong et al. 2014 and Supporting Information | b; Wong et al. 2014 |
Fluciclovine (anti-1-Amino-3-18F-fluorocyclobutane-1-carboxylic acid) | [18F]FACBC; Auxumin | Amino acid transport | c; Sörensen et al. 2013 | Nye et al. 2007; McParland et al. 2010 | b; Songmen et al. 2019 |
[18F]Fluoroazomycin arabinoside | [18F]FAZA | Tumor hypoxia | Shao et al. 2011b | Savi et al. 2017 | Beck et al., 2007 |
2-[18F]Fluoro-2-deoxy-D-glucose | [18F]FDG | Glucose metabolism | Richards and Scott 2012; Sowa et al. 2018 | Srinivasan et al. 2020 | Koeppe et al. 2005 |
[18F]6-Fluoro-L-DOPA | [18F]FDOPA | Dopamine | See Supporting Information, Mossine et al. 2019, 2020 | Kaushik et al. 2013; Mejia et al. 1991 | Minn et al. 2009 |
[18F]-Fluoroethoxy- benzovesamicol | [18F]FEOBV | Vesicular acetylcholine transporter | Shao et al. 2011b | Petrou et al. 2014 | Petrou et al. 2014 |
[18F]Fluorocholine | [18F]FCH | Choline biochemistry | Rodnick et al. 2013 | DeGrado et al. 2002; Fabbri et al. 2014 | Davenport et al. 2020 |
[18F]Florbetapir | Amyvid; [18F]AV45 | Amyloid plaques | c | Joshi et al. 2014 | Frey and Koeppe 2016 |
[18F]-Fluoro-3′-deoxy-3′-L-fluorothymidine | [18F]FLT | Cellular proliferation | Shao et al. 2011b | Vesselle et al. 2003; Mendes et al. 2018 | Bertagna et al. 2013 |
[18F]Flubatine | [18F]FLBT | α4β2 nAChR | Hockley et al. 2013 | Kranz et al. 2016 | Sattler et al. 2012 |
[18F]Flutemetamol | Vizamyl, [18F]GE67 | Amyloid plaques | c; Snellman et al. 2014 | Koole et al. 2009 | Frey and Koeppe 2016 |
[18F]Fluoromisonidazole | [18F]FMISO | Tumor hypoxia | d; Riss et al. 2012 | Graham et al. 1997 | Bruehlmeier et al. 2004 |
[18F]Fluoropropyl-dihydrotetrabenazine | [18F]FP-TBZ, [18F]AV133 | VMAT2 | Lin et al. 2010 | Lin et al. 2010 | Kilbourn and Koeppe 2019 |
[18F]GBR13119 /[18F]GBR12909 | [18F]GBR | DAT | Haka and Kilbourn 1988, 1990 | Kilbourn et al. 1989 | Koeppe et al. 1990b |
4-[18F]Fluoro-m-hydroxyphenethylguanidine | [18F]MHPG | NET | Raffel et al. 2018 | Raffel et al. 2018 | Raffel et al. 2018 |
2′-Methoxyphenyl-(N-2′-pyridinyl)-p-18F-fluoro-benzamidoethylpiperazine | [18F]MPPF | 5-HT1A Receptor | Shao et al. 2011b | See Supporting Information | b; Aznavour and Zimmer 2007 |
[18F]Sodium Fluoride | [18F]NaF | Bone imaging | Shao et al. 2011b | Segall et al. 2010; Silveira et al. 2010 | Wong and Piert 2013 |
[18F]N-Methyl Lansoprazole | [18F]NML | Tau | Kramer et al. 2020 | Kramer et al. 2020 | Kramer et al. 2020 |
4-[18F]Fluoro-p-hydroxyphenethylguanidine | [18F]PHPG | NET | Raffel et al. 2018 | Raffel et al. 2018 | Raffel et al. 2018 |
Other Radiotracers | |||||
[13N]Ammonia | [13N]NH3 | Blood flow | Scott 2012 | Yi et al. 2015 | Beanlands et al. 1994 |
[15O]Water | [15O]H2O | Blood flow | Dick and Watkins 2015 | Brihaye et al. 1995 | Minoshima et al. 1993 |
[68Ga]DOTATATE | NETSPOT | Somatostatin receptors | NETSPOT prescribing information 2016 | Walker et al. 2013 | b; Fallahi et al. 2019 |
[68Ga]PSMA-HBEDCC | [68Ga]PSMA-11 | Prostate specific membrane antigen | See Supporting Information; Rodnick et al. 2020 | Afshar-Oromieh et al. 2016; Sandgren et al. 2019 | Rodnick et al. 2020 |
aHistorical dosimetry data is no longer extant. Biodistribution data are provided to enable estimation of dosimetry; b UM Imaging data not yet published; c Commercially available under an approved (A)NDA; d Commercially available under an IND